McDonald, LC, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clostridium difficile 2018;66(7):e1–e48.
Olsen, MA, Young-Xu, Y, Stwalley, D, et al. The burden of Clostridium difficile infection: estimates of the incidence of CDI from US administrative databases. BMC Infect Dis 2016;16:177–184.
Dubberke, ER, Olsen, MA, Stwalley, D, et al. Identification of Medicare recipients at highest risk for Clostridium difficile infection in the US by population attributable risk analysis. PLoS One 2016;11(2):e0146822.
Baggs, J, Yousey-Hindes, K, Ashley, ED, et al. Identification of a population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials. Vaccine 2015;33:6241–6249.
Lessa, FC, Winston, LG, McDonald, LC, Emerging Infections Program C. difficile Surveillance Team. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372:2369–2370.
Gutiérrez, RL, Riddle, MS, Porter, CK. Epidemiology of Clostridium difficile infection among active duty United States military personnel (1998–2010). BMC Infect Dis 2013;13:609–616.
Dantes, R, Mu, Y, Hicks, LA, et al. Association between outpatient antibiotic prescribing practices and community-associated Clostridium difficile infection. Open Forum Infect Dis 2015;2(3):ofv113.
Delate, T, Albrecht, G, Won, K and Jackson, A. Ambulatory-treated Clostridium difficile infection: a comparison of community-acquired vs. nosocomial infection. Epidemiol Infect 2015;143:1225–1235.
Khanna, S, Pardi, DS, Aronson, SL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012;107:89–95.
Kuntz, JL, Johnson, ES, Raebel, MA, et al. Epidemiology and healthcare costs of incident Clostridium difficile infections in the outpatient healthcare setting. Infect Control Hosp Epidemiol 2012;33:1031–1038.
Kuntz, JL, Chrischilles, EA, Pendergast, JF, Herwaldt, LA, Polgreen, PM. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis 2011;11:194–200.
Young-Xu, Y, Kuntz, JL, Gerding, DN, et al.
Clostridium difficile infection among Veterans Health Administration patients. Infect Control Hosp Epidemiol 2015;36:1038–1045.
Evans, ME, Simbartl, LA, Kralovic, SM, Jain, R, Roselle, GA.
Clostridium difficile infections in Veterans Health Administration acute care facilities. Infect Control Hosp Epidemiol 2014;35:1037–1042.
Reveles, KR, Lawson, KA, Mortensen, E, et al. National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014. PLoS One 2017;12(12):e.0189227.
Reveles, KR, Pugh, MJV, Lawson, KA, et al. Shift to community-onset Clostridium difficile infection in the national Veterans Health Administration 2003–2014. Am J Infect Control 2018;46:431–435.
Pinzon, MCM, Buie, R, Liou, J, et al. Outcomes of community and healthcare onset Clostridium difficile infection. Clin Infect Dis 2019;68:1343–1350.
Gutiérrez, RL, Riddle, MS, Porter, CK. Increased risk of functional gastrointestinal sequelae after Clostridium difficile infection among active duty United States military personnel (1998–2010). Gastroenterology 2015;149:1408–1414.
Hauser, RG, Quine, DB, Ryder, A. LabRS: A Rosetta stone for retrospective standardization of clinical laboratory test results. J Am Med Informat Assoc 2018;25:121–126.
Austin, PC, Stuart, EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Statist Med 2015;34:3661–3679.
Perneger, TV. What’s wrong with Bonferroni adjustments. Brit Med J 1998;316:1236–1238.
Guh, AY, Mu, Y, Baggs, J, et al. Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011–2015. Am J Infect Control 2018;46:840–842.
Giancola, SE, Williams, RJ II, Gentry, CA. Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health Administration. Clin Microbiol Infect 2018;24:877–881.
Reeves, JS, Evans, ME, Simbartl, LA, et al.
Clostridium difficile infections in Veterans Health Administration long-term care facilities. Infect Control Hosp Epidemiol 2016;37:295–300.
Evans, ME, Kralovic, SM, Simbartl, LA, Jain, R, Roselle, GA. Effect of a Clostridium difficile infection prevention initiative in Veterans Affairs acute care facilities. Infect Control Hosp Epidemiol 2016;37:720–722.
Loo, VG, Bourgault, A, Poirier, L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365:1693–1703.
Durham, DP, Olsen, MA, Dubberke, ER, Galvani, AP, Townsend, JP. Quantifying transmission of Clostridium difficile within and outside healthcare settings. Emerg Infect Dis 2016;22:608–616.
Kumar, N, Miyajima, F, He, M, et al. Genome-based infection tracking reveals dynamics of Clostridium difficile transmission and disease recurrence. Clin Infect Dis 2016;62:746–752.
Goto, M, Ohl, ME, Schweizer, ML, Perencevich, EN. Accuracy of administrative code data for the surveillance of healthcare-associated infections: a systematic review and meta-analysis. Clin Infect Dis 2014;58:688–696.
Petersen, LA, Byrne, MM, Daw, CN, Hasche, J, Reis, B, Pietz, K. Relationship between clinical conditions and use of Veterans Affairs health care among Medicare-enrolled Veterans. Health Services Research 2010;45:762–791.
Kuntz, JL, Polgreen, PM. The importance of considering different healthcare settings when estimating the burden of Clostridium difficile
. Clin Infect Dis 2015;60:831–836.
Rogers, WH, Kazis, LE. Comparing the health status of VA and non-VA ambulatory patients: the Veterans’ Health and Medical Outcomes Studies. J Ambulatory Care Manag 2004;27:249–262.